3rd Quarter - Report

VALNEVA USA, INC. for VALNEVA USA, INC.

Firm
Client
Income
—
Expenses
$220,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

ACA coverage for all adult vaccines (regulation related to Public Health Service Act, Sec 2713); Appropriations related to CDC report on arbovirus threat; Appropriations related to funding the State Stockpile Grant program; Issues related to Strategic National Stockpile procurement regarding new emerging infection diseases and in relation to the Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization; Issues related to the FDA's Tropical Priority Review Voucher; Issues related to reauthorization of the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE)

Foreign entity interest: Foreign entities identified on form LD-1 have an interest in the lobbying issues.

LobbyistCovered position, as disclosed
AMANDA ARNOLD —
JOHN KANARAS —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.